Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Inactivation of CYP2A6 and CYP2A13 during nicotine metabolism
Linda B. Von Weymarn
, Kathryn M. Brown
,
Sharon E. Murphy
Carcinogenesis and Chemoprevention
Biochemistry, Molecular Biology, and Biophysics (TMED)
Office of Academic Clinical Affairs
Research output
:
Contribution to journal
›
Article
›
peer-review
50
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Inactivation of CYP2A6 and CYP2A13 during nicotine metabolism'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Nicotine Metabolism
100%
CYP2A6
100%
CYP2A13
100%
Nicotine
50%
Cotinine
30%
Tobacco
20%
Metabolism
20%
Trans-3′-hydroxycotinine
20%
Enzyme Inactivation
20%
Iminium Ion
20%
Dialysis
10%
Carcinogen
10%
Mechanism-based
10%
Enzyme Activity
10%
Hydroxymethyl
10%
Pyridyl
10%
Metabolic Activation
10%
Nicotinamide Adenine Dinucleotide Phosphate (NADPH)
10%
Ultra-high Performance Liquid Chromatography (UHPLC)
10%
Alternative Substrates
10%
Aldehyde Oxidase
10%
Short Reaction Time
10%
Norcotinine
10%
Primary Catalyst
10%
2-Butanone
10%
Pharmacology, Toxicology and Pharmaceutical Science
CYP2A6
100%
Cotinine
75%
Carcinogen
25%
NNK
25%
2 Butanone
25%
Reduced Nicotinamide Adenine Dinucleotide Phosphate
25%
Hyperbarism
25%
Aldehyde Oxidase
25%
Immunology and Microbiology
Metabolite
100%
Enzyme Inactivation
66%
Liquid Chromatography
33%
Enzyme Activity
33%
Metabolic Activation
33%